InvestorsHub Logo
Followers 7
Posts 289
Boards Moderated 0
Alias Born 12/11/2013

Re: biodoc post# 154164

Friday, 07/08/2016 5:27:02 PM

Friday, July 08, 2016 5:27:02 PM

Post# of 403024
I agree bio, either one off the licensing deals for each indication or do an all encompassing B platform deal with upfront cash, milestone payments, and share of profits. Haven't other biotechs done this? Isn't that how Pharmacyclics ended up being sold for $21 Billion for the half of their platform they still owned?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News